Your browser doesn't support javascript.
loading
Atypical presentation of varicella-zoster virus reactivation in a lung transplant patient: a case report.
Hoff, Ingrid; Rath, Eivind; Pena-Karan, Slobodanka; Sivy Nginamau, Elisabeth; Holm, Are Martin; Thune, Turid; Mustafa, Tehmina.
Affiliation
  • Hoff I; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Rath E; Department of Medicine, Telemark Hospital Trust, Porsgrunn, Norway.
  • Pena-Karan S; Department of Medicine section of Infectious Diseases, Haukeland University Hospital, Bergen, Norway.
  • Sivy Nginamau E; Department of Emergency Medicine, Haukeland University Hospital, Bergen, Norway.
  • Holm AM; Department of Radiology, Haukeland University Hospital, Bergen, Norway.
  • Thune T; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
  • Mustafa T; Department of Respiratory Medicine, Oslo University Hospital, Oslo, Norway.
Access Microbiol ; 6(7)2024.
Article in En | MEDLINE | ID: mdl-39130743
ABSTRACT
Background. Varicella-zoster virus (VZV) is a human neurotropic virus which commonly causes infection during childhood, presenting as chickenpox. Later in life it may reactivate as herpes zoster. We report a rare manifestation of reactivation of VZV infection presenting as cutaneous vasculitis and varicella pneumonia in a lung transplant recipient. Case presentation. A 65-year-old man was lung transplanted bilaterally for emphysema and had repeated posttransplant chest infections and colonization with Pseudomonas aeruginosa. Nine months post-transplant he presented with dyspnoea and a cutaneous vasculitis-like eruption with a predilection over face, thorax and distal extremities. Initially, VZV reactivation was not suspected due to absence of the typical vesicular eruptions. The diagnosis was confirmed by VZV PCR from the swabs of the ulcer after skin punch biopsy of a lesion and from bronchoalveolar lavage (BAL). The histology of skin biopsy demonstrated epithelial damage and vascular damage but no typical epithelial virus associated changes. The patient responded to antiviral therapy with total remission of rash and VZV DNA was finally not detectable from repeated BAL after 29 days of therapy. However, the pulmonary radiological features and dyspnoea persisted due to reasons possibly unrelated to the VZV infection. Conclusion. Had it not been for the patient to mention the resemblance of the vasculitic rash with his primary VZV infection, the diagnosis would easily have been overlooked. In this case, the biopsy did not show typical histopathologic findings of VZV-vasculitis. What led the diagnosis was a PCR from the wound swab taken after the punch biopsy. This case serves as a reminder for atypical presentation of common conditions in immunosuppressed patients and that extensive diagnostic sampling may be warranted in this group.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Access Microbiol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Access Microbiol Year: 2024 Document type: Article